News
18/11/2021

New regulatory framework for low-risk drugs

ANVISA recently published Resolution No. 576/2021 with the aim of simplifying the notification procedure for low-risk drugs.

Marianne Albers and Thais Fernandes have written an Alert, in Portuguese, explaining in detail how the new notification process works.

Read more at: https://bit.ly/3HDcCaj